Rising Demand for Minimally Invasive Surgeries and Focus on Infection Control Driving Demand for Automated Endoscope Reprocessors
Rockville , Dec. 21, 2023 (GLOBE NEWSWIRE) — The global automated endoscope reprocessor market is estimated to reach a value of US$ 491.7 million in 2024 and is predicted to expand at a CAGR of 7.1% from 2024 to 2034. Factors such as rising number of endoscopy procedures, growing need for infection control, and technological advancements in reprocessing systems are driving market expansion.
The global market for automated endoscope reprocessors (AERs) has grown significantly in recent years, owing to developments in healthcare infrastructure and the rising prevalence of gastrointestinal illnesses. Demand for automated endoscope reprocessors is increasing, as hospitals, ambulatory surgical centers, and specialized clinics seek efficient and dependable endoscope reprocessing solutions.
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9261
Increasing acceptance of minimally invasive techniques is one of the key reasons driving market expansion. As endoscopy becomes more widely used for detecting and treating gastrointestinal diseases, the necessity of effective endoscope reprocessing becomes critical. Automated endoscope reprocessors provide uniformity, reliability, and efficiency in the disinfection and sterilizing process, lowering the risk of infection and assuring patient safety.
| Report Attribute | Details |
| Value Projection (2034) | US$ 978.8 Million |
| Growth Rate (2024-2034) | 7.1 % CAGR |
| No. of pages | 170 Pages |
| No. of Tables | 84 Tables |
| No. of Figures | 112 Figures |
Key Takeaways from Market Study
- The global automated endoscope reprocessor market stands at US$ 491.7 million in 2024.
- Demand for automated endoscope reprocessors is projected to rise at a noteworthy CAGR of 7.1% from 2024 to 2034.
- The market is forecasted to reach US$ 978.8 million by 2034-end.
- The market in East Asia is projected to expand at a CAGR of 7.3% through 2034.
- The standalone automated endoscopic reprocessors segment is forecasted to expand at a CAGR of 7.1% throughout the forecast period.
- North America is estimated to account for 36.6% share of the global market in 2024.
“The market for automated endoscope reprocessors is undergoing a transformation, driven by the pressing need for stringent infection control measures in healthcare facilities. The increased emphasis on patient safety, as well as technological improvements in reprocessing systems, are transforming the landscape and providing exciting prospects for market players,” says a Fact.MR analyst.
Key Companies Profiled in This Report
- HOYA Corporation
- Ecolab Inc.
- Custom Ultrasonics, Inc.
- ARC Group of Companies Inc.
- STERIS
- Olympus Corporation
- ASP
- SHINVA MEDICAL INSTRUMENT CO., LTD.
- Ottomed Endoscopy
- Advanced Sterilization Products Services Inc
- Laboratory Anios
- Getinge AB
- Metull Zug AG
- Steelco S.p.A.
- Cantel Medical Corp.
- Johnson & Johnson
Emphasis on Infection Control Propelling Adoption of Automated Endoscope Reprocessors in Healthcare Facilities Worldwide
With increased awareness of healthcare-associated infections and the crucial need for severe infection prevention measures, automated endoscope reprocessors have emerged as essential tools in guaranteeing patient safety. These systems are critical in reducing the risk of infection associated with endoscopic treatments, which are commonly used to diagnose and treat gastrointestinal diseases. The complexity of endoscopes, with complicated channels and components, makes manual cleaning and disinfection difficult, making automated reprocessors an essential alternative.
Automated endoscope reprocessors use modern technologies and authorized reprocessing methods to ensure thorough cleaning, high-level disinfection, and sterilization of endoscopes, reducing the risk of infectious agent transfer between patients. As healthcare facilities prioritize patient safety and infection control, the demand for automated endoscope reprocessors grows, prompting technological breakthroughs and innovations in reprocessing systems to improve their efficacy and dependability.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9261
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the automated endoscope reprocessor market for 2018 to 2023 and forecast statistics for 2024 to 2034.
The study divulges essential insights into the market based on product type (single-basin automated endoscopic reprocessors, dual-basin automated endoscopic reprocessors), modality (standalone automated endoscopic reprocessors, table/bench top automated endoscopic reprocessors), and end user (hospitals, ambulatory surgical centers, specialty clinics, others), across six major regions of the world (North America, Latin America, Europe, East Asia, South Asia & Oceania, and MEA).
Explore More Related Studies Published by Fact.MR Research:
Endoscope Flushing Pumps Market: The endoscope flushing pumps market is expected to grow at a CAGR of 6.2% during the forecast period of 2021-2031.
Endoscope Cleaning Products Market: According to recent research by Fact MR, the endoscope cleaning products market is anticipated to witness 7.8% growth during the forecast period from 2021 to 2031.
Disposable Endoscopes Market: The global disposable endoscopes market is anticipated to hold a value of US$ 2.1 Billion in 2022 and reach US$ 9.26 Billion by 2032.
About Fact.MR:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
- Nilfisk reports Q1 2025 results: Financial results in line with expectations – 2025 guidance maintained - May 13, 2025
- Jeito Capital leads EUR 132 million oversubscribed Series B financing in Azafaros to advance Phase 3 clinical programs of innovative therapies in rare inherited neuro-metabolic disorders - May 13, 2025
- NMD Pharma to present compelling preclinical data highlighting the potential of ClC-1 ion channel inhibition to improve disease symptoms and progression in MuSK myasthenia gravis at the MGFA International Conference on Myasthenia and Relate - May 13, 2025
